UBS Maintains a 'Buy' on Allergen (AGN); Another Strong R&D Day
Tweet
Share
E-mailGet Alerts AGN Hot Sheet
Price: $193.02 --0%
Rating Summary:
8 Buy, 20 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 20 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Buy' on Allergen (NYSE: AGN) price target raised from $100 to $107.
Analyst, Marc Goodman, said, "The pipeline stretches across the risk spectrum, including several pot blockbuster opportunities (Latisse scalp, Botox OA, Senrebotase for pain, a SR platform for glaucoma and several dry and wet AMD programs). We are very excited about the Latisse hair growth opportunity, and the key Phase II trials vs Minoxidil finish up later this year. But what was new and very impressive is the new osteoarthritis opportunity for Botox which just started Phase I/II studies as well as Senrebotase, the targeted toxin for pain that can be dosed at 1000x that of Botox because it targets only pain nerves and has no muscle effects."
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $94.05 yesterday.
Analyst, Marc Goodman, said, "The pipeline stretches across the risk spectrum, including several pot blockbuster opportunities (Latisse scalp, Botox OA, Senrebotase for pain, a SR platform for glaucoma and several dry and wet AMD programs). We are very excited about the Latisse hair growth opportunity, and the key Phase II trials vs Minoxidil finish up later this year. But what was new and very impressive is the new osteoarthritis opportunity for Botox which just started Phase I/II studies as well as Senrebotase, the targeted toxin for pain that can be dosed at 1000x that of Botox because it targets only pain nerves and has no muscle effects."
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $94.05 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
